Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor palbociclib

被引：4
|
作者：
Romagnuolo, Maurizio [1 ,2 ]
Alberti Violetti, Silvia [1 ,2 ]
Riva, Davide [1 ,2 ]
Barberi, Francesco [1 ,2 ]
Moltrasio, Chiara [2 ,3 ]
机构：
[1] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy
[3] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1111/ijd.16356
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E98 / E100
页数：3
相关论文
共 50 条
  • [1] Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
    Gao, Shan
    Wei, Guanjing
    Hao, Yanrong
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [2] Vitiligo-Like Lesions Induced by Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib: A Case Report and Literature Review
    Choukri Elm’hadi
    Meryem Zerrik
    Youssef Zemmez
    Rachid Tanz
    Indian Journal of Gynecologic Oncology, 2025, 23 (2)
  • [3] Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review
    Sharaf, Baha'
    AlMasri, Rama
    Abdel-Razeq, Nayef
    Salama, Osama
    Hamad, Ibrahim
    Abunasser, Mahmoud
    Abdel-Razeq, Hikmat
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 5 - 10
  • [4] Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
    Bang, Alexander S.
    Fay, Christopher J.
    LeBoeuf, Nicole R.
    Etaee, Farshid
    Leventhal, Jonathan S.
    Sibaud, Vincent
    Arbesman, Joshua
    Wang, Jennifer Y.
    Kwong, Bernice Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (03) : 643 - 647
  • [5] Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors
    Alexander S. Bang
    Christopher J. Fay
    Nicole R. LeBoeuf
    Farshid Etaee
    Jonathan S. Leventhal
    Vincent Sibaud
    Joshua Arbesman
    Jennifer Y. Wang
    Bernice Y. Kwong
    Breast Cancer Research and Treatment, 2024, 204 : 643 - 647
  • [6] Differences of cyclin-dependent kinase 4/6 inhibitor, palbociclib and abemaciclib, in breast cancer
    Tamura, Kenji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 993 - 998
  • [7] Cyclin-Dependent Kinase 4/6 Inhibitor (Palbociclib) Induced Aplastic Anemia in a Patient with Metastatic Breast Cancer
    Nwabudike, Stanley Madu
    Edwards, Camille V.
    Akinboro, Oladimeji
    Quinn, Kathryn
    Sarosiek, Shayna
    Ko, Naomi
    CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [8] Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients
    Tamura, Kenji
    Mukai, Hirofumi
    Naito, Yoichi
    Yonemori, Kan
    Kodaira, Makoto
    Tanabe, Yuko
    Yamamoto, Noboru
    Osera, Shozo
    Sasaki, Masaoki
    Mori, Yuko
    Hashigaki, Satoshi
    Nagasawa, Takashi
    Umeyama, Yoshiko
    Yoshino, Takayuki
    CANCER SCIENCE, 2016, 107 (06) : 755 - 763
  • [9] Palbociclib-Induced Vitiligo-Like Lesions: A Report of a Challenging Case
    Algethami, Abdulmohsin K.
    Alshareef, Alhusain M.
    Alhawsawi, Waseem K.
    Bader, Bader A.
    Alharbi, Arwa
    Alahmadi, Raneem
    Alsatti, Hanadi
    Abualola, Amal H.
    Alqahtani, Raneem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [10] Severe drug eruption induced by cyclin-dependent kinase 4 and 6 inhibitor
    Hashimoto, Hiroki
    Ito, Takamichi
    Ohno, Fumitaka
    Morisawa, Hiromi
    Furue, Masutaka
    JOURNAL OF DERMATOLOGY, 2021, 48 (07): : E339 - E340
12345